Authors and Disclosures
Mark J. Alberts, MD, Professor of Neurology, Department of Neurology, Northwestern University Feinberg School of Medicine, Chicago, Illinois; Director, Stroke Program, Northwestern Memorial Hospital, Chicago, Illinois
Disclosure: Mark J. Alberts, MD, has disclosed that he has served as a consultant to AGA Medical, AstraZeneca Pharmaceuticals LP, Bayer HealthCare Pharmaceuticals, Bristol-Myers Squibb Company, Boehringer Ingelheim Pharmaceuticals, Inc., Eli Lilly and Company, Genentech, Inc., Kos Pharmaceuticals, Inc., Medicines Company, Merck & Co., Inc., Novo Nordisk, PDL BioPharma, Inc., Pfizer Inc., and sanofi-aventis. Dr. Alberts has also disclosed that he has received research grants from AGA Medical, AstraZeneca Pharmaceuticals LP, Bristol-Myers Squibb Company, Boehringer Ingelheim Pharmaceuticals, Inc., Novo Nordisk, Photo Thera, sanofi-aventis, and Schering-Plough Corporation. Dr. Alberts has also disclosed that he has served on the speaker's bureaus of AstraZeneca Pharmaceuticals LP, Bristol-Myers Squibb Company, Boehringer Ingelheim Pharmaceuticals, Inc., diaDexus, Inc., Genentech, Inc., The Medicines Company, Medscape, Novo Nordisk, PDL BioPharma, Inc., and sanofi-aventis. Dr. Alberts has also disclosed that he has served on the advisory boards of AGA Medical, AstraZeneca Pharmaceuticals LP, Bristol-Myers Squibb Company, Boehringer Ingelheim Pharmaceuticals, Inc., Eli Lilly and Company, Genentech, Inc., Kos Pharmaceuticals, Inc., The Medicines Company, Medscape, Novo Nordisk, Pfizer Inc., and sanofi-aventis. Dr. Alberts has also disclosed that he has served on the review panel of Mitsubishi Pharma America, TAP Pharmaceuticals (Data Safety Monitoring Board), and Schering-Plough Corporation. Dr. Alberts has disclosed that he has received honoraria from AGA Medical, AstraZeneca Pharmaceuticals LP, Bayer HealthCare Pharmaceuticals, Bristol-Myers Squibb Company, Boehringer Ingelheim Pharmaceuticals, Inc., diaDexus, Inc., Eli Lilly and Company, Genentech, Inc., Kos Pharmaceuticals, Inc., The Medicines Company, Medscape, Merck & Co., Inc., Novo Nordisk, PDL BioPharma, Inc., Pfizer Inc., sanofi-aventis, TAP Pharmaceuticals, and Schering-Plough Corporation. Dr. Alberts has also disclosed that he has received royalties from Duke University/Athena Diagnostics for an ApOE Genotype Test.
Comments